In vitro microtumors provide a physiologically predictive tool for breast cancer therapeutic screening

PLoS ONE

Volumn 10, Issue 4, 2015, Pages

  Benton, Gabriel ^a   DeGray, Gerald ^a   Kleinman, Hynda K ^a   George, Jay ^a   Arnaoutova, Irina ^a  

^a TREVIGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; FLUOROURACIL; GLUCOSE; PACLITAXEL;

ACIDITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; BREAST CANCER CELL LINE; CANCER SCREENING; CELL INVASION; CELL LABELING; CELL PROLIFERATION; CELL STRUCTURE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; HYPOXIA; IN VITRO STUDY; MCF 7 CELL LINE; MDA MB 231 CELL LINE; MICROTUMOR MODEL; STROMA CELL; TUMOR MODEL; TUMOR VOLUME; UMBILICAL VEIN ENDOTHELIAL CELL; BREAST NEOPLASMS; CELL HYPOXIA; DRUG EFFECTS; FEMALE; GENETICS; MULTICELLULAR SPHEROID; PATHOLOGY; TUMOR INVASION; TUMOR MICROENVIRONMENT;

BOVINAE;

BREAST NEOPLASMS; CELL HYPOXIA; CELL PROLIFERATION; EXTRACELLULAR MATRIX; FEMALE; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; IN VITRO TECHNIQUES; MCF-7 CELLS; NEOPLASM INVASIVENESS; SPHEROIDS, CELLULAR; TUMOR MICROENVIRONMENT;

EID: 84927555905     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0123312     Document Type: Article

References (53)

1. Herper M. The Cost Of Creating A New Drug Now $5 Billion, Pushing Big Pharma To Change. Forbes. [Magazine]. 2013 8/11/2013(http://www.forbes.com/sites/matthewherper/2013/08/11/how-the-staggering-cost-of-inventing-new-drugs-is-shaping-the-future-of-medicine/).
2. Benton G, George J, Kleinman HK, Arnaoutova IP. Advancing science and technology via 3D culture on basement membrane matrix. Journal of Cellular Physiology. 2009; 221(1):18-25. doi: 10.1002/jcp.21832 PMID: 19492404
3. Kenny PA, Lee GY, Myers CA, Neve RM, Semeiks JR, Spellman PT, et al. The morphologies of breast cancer cell lines in three-dimensional assays correlate with their profiles of gene expression. Mol Oncol. 2007 Jun; 1(1):84-96. doi: 10.1016/j.molonc.2007.02.004 PMID: 18516279
4. Benton G, Crooke E, George J. Laminin-1 induces E-cadherin expression in 3-dimensional cultured breast cancer cells by inhibiting DNA methyltransferase 1 and reversing promoter methylation status. FASEB J. 2009 November 1, 2009; 23(11):3884-95. doi: 10.1096/fj.08-128702 PMID: 19635753
5. Lam CR, Wong HK, Nai S, Chua CK, Tan NS, Tan LP. A 3D Biomimetic Model of Tissue Stiffness Interface for Cancer Drug Testing. Mol Pharm. 2014 Jul 7; 11(7):2016-21. doi: 10.1021/mp500059q PMID: 24754837
6. Casazza A, Di Conza G, Wenes M, Finisguerra V, Deschoemaeker S, Mazzone M. Tumor stroma: a complexity dictated by the hypoxic tumor microenvironment. Oncogene. 2014 Apr 3; 33(14):1743-54. doi: 10.1038/onc.2013.121 PMID: 23604130
7. Parks SK, Mazure NM, Counillon L, Pouyssegur J. Hypoxia promotes tumor cell survival in acidic conditions by preserving ATP levels. J Cell Physiol. 2013 Sep; 228(9):1854-62. doi: 10.1002/jcp.24346 PMID: 23459996
8. Dai Y, Bae K, Siemann DW. Impact of Hypoxia on the Metastatic Potential of Human Prostate Cancer Cells. International Journal of Radiation Oncology∗Biology∗Physics. 2011; 81(2):521-8.
9. Ryu MH, Park HM, Chung J, Lee CH, Park HR. Hypoxia-inducible factor-1alpha mediates oral squamous cell carcinoma invasion via upregulation of alpha-5 integrin and fibronectin. Biochemical and Biophysical Research Communications. 2010; 393(1):11-5. doi: 10.1016/j.bbrc.2010.01.060 PMID: 20097172
10. Sullivan NJ, Sasser AK, Axel AE, Vesuna F, Raman V, Ramirez N, et al. Interleukin-6 induces an epi-thelial- mesenchymal transition phenotype in human breast cancer cells. Oncogene. 2009 Aug 20; 28 (33):2940-7. doi: 10.1038/onc.2009.180 PMID: 19581928
11. Neiva K, Warner K, Campos M, Zhang Z, Moren J, Danciu T, et al. Endothelial cell-derived interleukin-6 regulates tumor growth. BMC Cancer. 2014; 14(1):99.
12. Nowicka A, Marini FC, Solley TN, Elizondo PB, Zhang Y, Sharp HJ, et al. Human Omental-Derived Adipose Stem Cells Increase Ovarian Cancer Proliferation, Migration, and Chemoresistance. PLoS ONE. 2013; 8(12):e81859. doi: 10.1371/journal.pone.0081859 PMID: 24312594
13. Suzuki K, Sun R, Origuchi M, Kanehira M, Takahata T, Itoh J, et al. Mesenchymal stromal cells promote tumor growth through the enhancement of neovascularization. Mol Med. 2011; 17(7-8):579-87. doi: 10.2119/molmed.2011.00259 PMID: 21912808
14. Walter M, Liang S, Ghosh S, Hornsby PJ, Li R. Interleukin 6 secreted from adipose stromal cells promotes migration and invasion of breast cancer cells. Oncogene. 2009 Jul 30; 28(30):2745-55. doi: 10.1038/onc.2009.130 PMID: 19483720
15. Benton G, Kleinman HK, George J, Arnaoutova I. Multiple uses of basement membrane-like matrix (BME/Matrigel) in vitro and in vivo with cancer cells. Int J Cancer. 2011 April 15, 2011; 128(8):1751-7. doi: 10.1002/ijc.25781 PMID: 21344372
16. Han J, Chang H, Giricz O, Lee GY, Baehner FL, Gray JW, et al. Molecular Predictors of 3D Morphogenesis by Breast Cancer Cell Lines in 3D Culture. PLoS Comput Biol. 2010; 6(2):e1000684. doi: 10.1371/journal.pcbi.1000684 PMID: 20195492
17. Guth U, Huang DJ, Huber M, Schotzau A, Wruk D, Holzgreve W, et al. Tumor size and detection in breast cancer: Self-examination and clinical breast examination are at their limit. Cancer Detection and Prevention. 2008; 32(3):224-8. doi: 10.1016/j.cdp.2008.04.002 PMID: 18790576
18. Thoma CR, Zimmermann M, Agarkova I, Kelm JM, Krek W. 3D cell culture systems modeling tumor growth determinants in cancer target discovery. Advanced Drug Delivery Reviews. 2014(0).
19. Friedrich J, Ebner R, Kunz-Schughart LA. Experimental anti-tumor therapy in 3-D: spheroids-old hat or new challenge? Int J Radiat Biol. 2007 Nov-Dec; 83(11- 12):849-71. PMID: 17613123
20. Dufau I, Frongia C, Sicard F, Dedieu L, Cordelier P, Ausseil F, et al. Multicellular tumor spheroid model to evaluate spatio-temporal dynamics effect of chemotherapeutics: application to the gemcitabine/ CHK1 inhibitor combination in pancreatic cancer. BMC Cancer. 2012; 12(1):15.
21. Lopez J, Poitevin A, Mendoza-Martinez V, Perez-Plasencia C, Garcia-Carranca A. Cancer-initiating cells derived from established cervical cell lines exhibit stem-cell markers and increased radioresistance. BMC Cancer. 2012; 12(1):48.
22. Benton G, Arnaoutova I, George J, Kleinman HK, Koblinski J. Matrigel: From discovery and ECM mimicry to assays and models for cancer research. Adv Drug Deliv Rev. 2014 Jul 2.
23. Chuang H-N, Lohaus R, Hanisch U-K, Binder C, Dehghani F, Pukrop T. Coculture System with an Organotypic Brain Slice and 3D Spheroid of Carcinoma Cells. 2013(80:) :e50881.
24. Flach EH, Rebecca VW, Herlyn M, Smalley KSM, Anderson ARA. Fibroblasts Contribute to Melanoma Tumor Growth and Drug Resistance. Molecular Pharmaceutics. 2011 2014/09/22; 8(6):2039-49. doi: 10.1021/mp200421k PMID: 22067046
25. Debnath J, Muthuswamy SK, Brugge JS. Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures. Methods. 2003 Jul; 30(3):256-68. PMID: 12798140
26. Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ: 25 years of image analysis. Nat Meth. 2012; 9(7):671-5.
27. Holliday DLDL. Choosing the right cell line for breast cancer research. Breast cancer research: BCR. 2011 2011; 13(4):215. doi: 10.1186/bcr2889 PMID: 21884641
28. Hirschhaeuser F, Menne H, Dittfeld C, West J, Mueller-Klieser W, Kunz-Schughart LA. Multicellular tumor spheroids: An underestimated tool is catching up again. Journal of Biotechnology. 2010; 148 (1):3-15. doi: 10.1016/j.jbiotec.2010.01.012 PMID: 20097238
29. Paszek MJ, Zahir N, Johnson KR, Lakins JN, Rozenberg GI, Gefen A, et al. Tensional homeostasis and the malignant phenotype. Cancer Cell. 2005; 8(3):241-54. PMID: 16169468
30. Vinci MM. Advances in establishment and analysis of 3D tumour spheroid-based functional assays for target validation and drug evaluation. BMC Biology. 2012 2012-03-22; 10(1):29.
31. Zeng W, Liu P, Pan W, Singh SR, Wei Y. Hypoxia and hypoxia inducible factors in tumor metabolism. Cancer Letters. (0).
32. Huang X, Zhou J, Liu J, Tang B, Zhao F, Qu Y. Biological characteristics of prostate cancer cells are regulated by hypoxia-inducible factor 1alpha. Oncol Lett. 2014 Sep; 8(3):1217-21. PMID: 25120692
33. Szalad A, Katakowski M, Zheng X, Jiang F, Chopp M. Transcription factor Sp1 induces ADAM17 and contributes to tumor cell invasiveness under hypoxia. Journal of Experimental & Clinical Cancer Research. 2009; 28(1):129.
34. Ji F, Wang Y, Qiu L, Li S, Zhu J, Liang Z, et al. Hypoxia inducible factor 1alpha-mediated LOX expression correlates with migration and invasion in epithelial ovarian cancer. Int J Oncol. 2013 May; 42 (5):1578-88. doi: 10.3892/ijo.2013.1878 PMID: 23545606
35. Santhanam AN, Baker AR, Hegamyer G, Kirschmann DA, Colburn NH. Pdcd4 repression of lysyl oxidase inhibits hypoxia-induced breast cancer cell invasion. Oncogene. 2010; 29(27):3921-32. doi: 10.1038/onc.2010.158 PMID: 20498644
36. Marconi C, Peppicelli S, Bianchini F, Calorini L. TNFalpha receptor1 drives hypoxia-promoted invasiveness of human melanoma cells. Exp Oncol. 2013 Sep; 35(3):187-91. PMID: 24084456
37. Su Y, Loos M, Giese N, Hines OJ, Diebold I, Gorlach A, et al. PHD3 regulates differentiation, tumour growth and angiogenesis in pancreatic cancer. Br J Cancer. 2010; 103(10):1571-9. doi: 10.1038/sj.bjc.6605936 PMID: 20978507
38. Wu W, Pan C, Meng K, Zhao L, Du L, Liu Q, et al. Hypoxia activates heparanase expression in an NFkappaB dependent manner. Oncol Rep. 2010 Jan; 23(1):255-61. PMID: 19956890
39. Shi CY, Fan Y, Liu B, Lou WH. HIF1 Contributes to Hypoxia-Induced Pancreatic Cancer Cells Invasion via Promoting QSOX1 Expression. Cellular Physiology and Biochemistry. 2013; 32(3):561-8. doi: 10.1159/000354460 PMID: 24008827
40. Peppicelli S, Bianchini F, Calorini L. Extracellular acidity, a "reappreciated" trait of tumor environment driving malignancy: perspectives in diagnosis and therapy. Cancer and Metastasis Reviews. 2014; 33 (2-3):823-32. doi: 10.1007/s10555-014-9533-1 PMID: 25365943
41. Yun J, Rago C, Cheong I, Pagliarini R, Angenendt P, Rajagopalan H, et al. Glucose deprivation contributes to the development of KRAS pathway mutations in tumor cells. Science. 2009 Sep 18; 325 (5947):1555-9. doi: 10.1126/science.1174229 PMID: 19661383
42. Sasser AK, Mundy BL, Smith KM, Studebaker AW, Axel AE, Haidet AM, et al. Human bone marrow stromal cells enhance breast cancer cell growth rates in a cell line-dependent manner when evaluated in 3D tumor environments. Cancer Letters. 2007; 254(2):255-64. PMID: 17467167
43. Olsen C, Moreira J, Lukanidin E, Ambartsumian N. Human mammary fibroblasts stimulate invasion of breast cancer cells in a three-dimensional culture and increase stroma development in mouse xenografts. BMC Cancer. 2010; 10(1):1-16.
44. Otvos L, Haspinger E, La Russa F, Maspero F, Graziano P, Kovalszky I, et al. Design and development of a peptide-based adiponectin receptor agonist for cancer treatment. BMC Biotechnology. 2011; 11 (1):90.
45. Arnaoutova I, George J, Kleinman H, Benton G. The endothelial cell tube formation assay on basement membrane turns 20: state of the science and the art. Angiogenesis. 2009; 12(3):267-74. doi: 10.1007/s10456-009-9146-4 PMID: 19399631
46. Zhang B, Yang S, Zhang Y, Sun Z, Xu W, Ye S. Co-culture of mesenchymal stem cells with umbilical vein endothelial cells under hypoxic condition. Journal of Huazhong University of Science and Technology [Medical Sciences]. 2012; 32(2):173-80.
47. Bocci G, Barbara C, Vannozzi F, Di Paolo A, Melosi A, Barsanti G, et al. A pharmacokinetic-based test to prevent severe 5-fluorouracil toxicity. Clin Pharmacol Ther. 2006 Oct; 80(4):384-95. PMID: 17015056
48. Eisenhauer EA, ten Bokkel Huinink WW, Swenerton KD, Gianni L, Myles J, van der Burg ME, et al. Eu-ropean- Canadian randomized trial of paclitaxel in relapsed ovarian cancer: high-dose versus low-dose and long versus short infusion. Journal of Clinical Oncology. 1994 December 1, 1994; 12(12):2654-66. PMID: 7989941
49. Vescio RA, Connors KM, Kubota T, Hoffman RM. Correlation of histology and drug response of human tumors grown in native-state three-dimensional histoculture and in nude mice. Proceedings of the National Academy of Sciences. 1991 June 15, 1991; 88(12):5163-6. PMID: 2052596
50. Nakayama S, Torikoshi Y, Takahashi T, Yoshida T, Sudo T, Matsushima T, et al. Prediction of paclitaxel sensitivity by CDK1 and CDK2 activity in human breast cancer cells. Breast Cancer Research. 2009; 11(1):R12. doi: 10.1186/bcr2231 PMID: 19239702
51. Kang NH, Hwang KA, Yi BR, Lee HJ, Jeung EB, Kim SU, et al. Human amniotic fluid-derived stem cells expressing cytosine deaminase and thymidine kinase inhibits the growth of breast cancer cells in cellular and xenograft mouse models. Cancer Gene Ther. 2012 Jun; 19(6):412-9. doi: 10.1038/cgt.2012.15 PMID: 22498724
52. Hongisto V, Jernstrom S, Fey V, Mpindi J-P, Kleivi Sahlberg K, Kallioniemi O, et al. High-Throughput 3D Screening Reveals Differences in Drug Sensitivities between Culture Models of JIMT1 Breast Cancer Cells. PLoS ONE. 2013; 8(10):e77232. doi: 10.1371/journal.pone.0077232 PMID: 24194875
53. Hotchkiss KA, Ashton AW, Mahmood R, Russell RG, Sparano JA, Schwartz EL. Inhibition of Endothelial Cell Function in Vitro and Angiogenesis in Vivo by Docetaxel (Taxotere): Association with Impaired Repositioning of the Microtubule Organizing Center 1 Supported by grants from the National Cancer Institute (Grants R01-CA54422, RO1-CA89352, and P01-CA13330), Aventis Pharmaceuticals, and UJA-Federation of New York. 1. Molecular Cancer Therapeutics. 2002 November 1, 2002; 1(13):1191-200. PMID: 12479700